Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma

Author： Carter Christopher   Chen Charles   Brink Cheryl   Vincent Patrick   Maxuitenko Yulia   Gilbert Karen   Waud William   Zhang Xiaomei  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.59, Iss.2, 2007-02, pp. : 183-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Docetaxel (taxotere(R)) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer

By Le Chevalier T.   Monnier A.   Douillard J.Y.   Ruffie P.   Sun X.S.   Belli L.   Ibrahim N.   Bougon N.   Berille J.  

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2032-2036

Elsevier

Access to resources Recommend Favorite

Antiangiogenic Agents in Combination with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer

By Ulahannan Susanna V.   Brahmer Julie R.  

Cancer Investigation, Vol. 29, Iss. 4, 2011-04 ,pp. : 325-337

Informa Healthcare

Access to resources Recommend Favorite

Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma - a multicentre phase I study

By Giannakakis T.   Ziras N.   Kakolyris S.   Mavroudis D.   Androulakis N.   Agelaki S.   Parashos M.   Sarra E.   Dimou T.   Hatzidaki D.   Vlachonikolis J.   Georgoulias V.  

European Journal of Cancer, Vol. 36, Iss. 6, 2000-04 ,pp. : 742-747

Elsevier

Access to resources Recommend Favorite

Paclitaxel by 1-h infusion in combination with carboplatin in advanced non-small cell lung carcinoma (NSCLC)

By Langer C.J.   McAleer C.A.   Bonjo C.A.   Litwin S.   Millenson M.   Kosierowski R.   Blankstein K.   Alexander R.   Ozols R.F.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 183-193

Elsevier

Access to resources Recommend Favorite

The role of new agents in the treatment of non-small cell lung cancer

By Broker L.E.   Giaccone G.  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2347-2361

Elsevier

Access to resources Recommend Favorite